COVID-19 and Cardiovascular Comorbidities-Reference-Cited by-同舟云学术

COVID-19 and Cardiovascular Comorbidities

Published:2020-11-06 Issue: Volume: Page:
ISSN:0947-7349
Container-title:Experimental and Clinical Endocrinology & Diabetes
language:en
Short-container-title:Exp Clin Endocrinol Diabetes

Author:

Müller-Wieland Dirk¹,Marx Nikolaus¹,Dreher Michael²,Fritzen Katharina³,Schnell Oliver³⁴

Affiliation:

1. Clinic for Cardiology, Angiology and Internal Care Medicine (Medical Clinic I) Universitatsklinikum Aachen, Aachen

2. Clinic for Pneumology and Internal Intensive Care Medicine (Medical Clinic V, Uniklinik RWTH Aachen, Aachen

3. Sciarc GmbH, Baierbrunn

4. Forschergruppe Diabetes e.V., Munich Neuherberg

Abstract

AbstractThe emergence of a new coronavirus - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - has resulted in a global pandemic. The associated coronavirus disease 2019 (COVID-19) has resulted in a high number of death worldwide. Observational studies and case reports have provided insights that older age and the presence of chronic diseases is frequently associated with a higher COVID-19 severity. These individuals also seem to have a higher risk of mortality due to COVID-19. In this review we provide insights into the impact chronic diseases associated with the cardiovascular system, such as obesity, diabetes mellitus, hypertension and cardiovascular disease might have on SARS-CoV-2 infection and COVID-19. Additionally we review recommendations and guidance’s of international scientific associations and discuss which key learnings might be of importance for the future.

Publisher

Georg Thieme Verlag KG

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1269-1405.pdf

Reference133 articles.

1. Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy;M Rizzo;JAMA Internal Medicine,2020

2. Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy;E Mannucci;Int J Infect Dis,2020

3. Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020;L S Vestergaard;Eurosurveillance,2020

4. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention;Z Wu;Jama,2020

5. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation;M Böhm;Clin Res Cardiol,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Electrocardiographic Patterns Related to Mortality with COVID-19;Applied Sciences;2024-01-18

2. The influence of comorbid diseases on the profiles of signaling biomarkers (macrophage-derived chemokine, interferon-γ-induced protein 10 kD, soluble CD40 ligand, vascular endothelial growth factor) and severity in patients with COVID-19: clinical studies;HERALD of North-Western State Medical University named after I.I. Mechnikov;2024-01-13

3. Outcomes of Liver Transplant Recipients Hospitalized with COVID-19: A Nationwide Analysis from the United States;Journal of Clinical and Experimental Hepatology;2024-01

4. Hyperglycaemia and Its Prognostic Value in Patients with COVID-19 Admitted to the Hospital in Lithuania;Biomedicines;2023-12-25

5. Pathomorphological Features of the Novel Coronavirus Disease in Patients with Systemic Amyloidosis;Biomedicines;2023-10-17